


Avenns Medical Revenue
Medical Equipment Manufacturing • Egger-Lienz Straße 1d, Innsbruck, Austria • 1-10 Employees
Avenns Medical revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contact at Avenns Medical
David Wagner
Director Of Sales & Marketing
Company overview
| Headquarters | Egger-Lienz Straße 1d, Innsbruck, Tyrol 6020, AT |
| Phone number | +4371411705 |
| Websites | |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Avenns Medical Email Formats
Avenns Medical uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@avenns.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@avenns.com | 100% |
About Avenns Medical
Regeneration of infarcted heart muscle remained a dream of modern medicine despite of comprehensive research on stem cell and gene therapy. Both technologies have not gained broad clinical use due to limited clinical results and significant side-effects including tumour formation. Shockwaves at low-energy levels are in broad clinical use for tissue regeneration in various indications, mainly in orthopaedics (see International Society of Medical Shockwave Treatment: www.ismst.com). It is therefore proven safe in millions of patients over more than 30 years. This distinguishes shockwave therapy clearly from all other regenerative therapy approaches! Our system is the first shockwave device for direct cardiac application during Coronary Artery Bypass Graft surgery (CABG) in the world. It induces tissue regeneration in infarcted heart muscle and thereby significantly improves heart function, i.e. left ventricular ejection fraction (LVEF). One key finding of our CAST-HF trial is the fact that direct cardiac shockwave therapy resulted in a significant improvement of LVEF at 12 months after the intervention. This results in an improvement of the patients’ physical capacity, increased quality of life and a prolonged life expectancy. While establishing cardiac shockwave therapy for the intraoperative use in cardiac surgery, we are in parallel developing a second-generation heart applicator for minimally invasive / interventional use in cardiology.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Avenns Medical has 2 employees across 2 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



